• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声引导下椎旁神经溶解阻滞:两例报告

Ultrasound-guided paravertebral neurolytic block: a report of two cases.

作者信息

Malik Tariq

机构信息

Department of Anesthesia and Critical Care, University of Chicago Medical Center, Chicago, Illinois, USA.

出版信息

Pain Pract. 2014 Apr;14(4):346-9. doi: 10.1111/papr.12072. Epub 2013 May 21.

DOI:10.1111/papr.12072
PMID:23692153
Abstract

Paravertebral block is commonly used in the treatment for acute and chronic pain. The duration of paravertebral block could theoretically be prolonged with neurolytic agents. We report two cases of ultrasound-guided neurolytic paravertebral blocks in patients suffering from intense cancer-related thoracic pain. Ultrasound was used to identify the space and plane of injection at the mid-thoracic level. Absolute alcohol was used to block the nerves at different segments. The two patients had great pain relief. Neurolytic paravertebral block can be a useful technique in patients with intractable cancer pain. Because of the risk of complication, it is recommended that this technique should be limited to relief of intractable pain in cancer patients with a poor prognosis.

摘要

椎旁阻滞常用于急慢性疼痛的治疗。理论上,使用神经溶解剂可延长椎旁阻滞的持续时间。我们报告了两例超声引导下对患有严重癌症相关胸痛患者进行神经溶解椎旁阻滞的病例。使用超声确定胸段中部的注射间隙和平面。使用无水乙醇对不同节段的神经进行阻滞。这两名患者的疼痛得到了极大缓解。神经溶解椎旁阻滞对于患有顽固性癌症疼痛的患者可能是一种有用的技术。由于存在并发症风险,建议将该技术仅限于缓解预后较差的癌症患者的顽固性疼痛。

相似文献

1
Ultrasound-guided paravertebral neurolytic block: a report of two cases.超声引导下椎旁神经溶解阻滞:两例报告
Pain Pract. 2014 Apr;14(4):346-9. doi: 10.1111/papr.12072. Epub 2013 May 21.
2
Neurolytic thoracic paravertebral block in cancer pain. A clinical report.癌症疼痛的神经溶解型胸段椎旁阻滞。一份临床报告。
Acta Anaesthesiol Scand. 1998 May;42(5):581-5. doi: 10.1111/j.1399-6576.1998.tb05170.x.
3
Video-assisted thoracoscopic neurectomy of intercostal nerves in a patient with intractable cancer pain.电视辅助胸腔镜下对一名顽固性癌痛患者进行肋间神经切除术
Am J Hosp Palliat Care. 2006;23(6):475-8. doi: 10.1177/1049909106294821.
4
Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer.用于治疗与癌症相关的慢性盆腔疼痛的神经溶解型上腹下丛阻滞术
Reg Anesth. 1997 Nov-Dec;22(6):562-8.
5
A retrospective review and treatment paradigm of interventional therapies for patients suffering from intractable thoracic chest wall pain in the oncologic population.肿瘤患者顽固性胸壁疼痛的介入治疗回顾性研究及治疗模式
Pain Med. 2015 Apr;16(4):802-10. doi: 10.1111/pme.12558. Epub 2014 Sep 19.
6
Ultrasound-guided thoracic paravertebral blockade: a cadaveric study.超声引导胸椎旁神经阻滞:尸体研究。
Anesth Analg. 2010 Jun 1;110(6):1735-9. doi: 10.1213/ANE.0b013e3181dd58b0. Epub 2010 Apr 30.
7
[Analgesic effect of neurolytic celiac plexus block guided by ultrasonography in advanced malignancies].超声引导下腹腔神经丛阻滞对晚期恶性肿瘤的镇痛效果
Zhonghua Yi Xue Za Zhi. 2001 Apr 10;81(7):418-21.
8
[Neurolytic blocks for cancer pain--still a useful therapeutic strategy].[用于癌症疼痛的神经溶解阻滞——仍然是一种有用的治疗策略]
Tidsskr Nor Laegeforen. 2004 Feb 19;124(4):481-3.
9
Thoracic paravertebral spread using two different ultrasound-guided intercostal injection techniques in human cadavers.在人体尸体中使用两种不同的超声引导肋间注射技术进行胸段椎旁扩散。
Clin Anat. 2010 Oct;23(7):840-7. doi: 10.1002/ca.21021.
10
Intrathecal neurolytic blocks for the relief of cancer pain.鞘内神经溶解阻滞用于缓解癌痛。
Best Pract Res Clin Anaesthesiol. 2003 Sep;17(3):407-28. doi: 10.1016/s1521-6896(03)00016-8.

引用本文的文献

1
Post-herpetic Neuralgia: A Systematic Review of Current Interventional Pain Management Strategies.带状疱疹后神经痛:当前介入性疼痛管理策略的系统评价
J Cutan Aesthet Surg. 2020 Oct-Dec;13(4):265-274. doi: 10.4103/JCAS.JCAS_45_20.
2
Interventional Techniques to Management of Cancer-Related Pain: Clinical and Critical Aspects.癌症相关疼痛管理的介入技术:临床与关键要点
Cancers (Basel). 2019 Mar 29;11(4):443. doi: 10.3390/cancers11040443.